Emoqol-100 : Development and validation of a single question for low mood in primary care. A retrospective audit
Copyright © 2023, The Authors..
BACKGROUND: Patients with depression need to be diagnosed and managed effectively in primary care. However, current inventories for case-finding low mood are time-consuming when considering the limited time available during appointments.
AIM: To validate the diagnostic accuracy of a single question on the emotional quality of life (Emoqol-100) as a measure of depression in symptomatic patients.
DESIGN & SETTING: A retrospective clinical audit, validating the Emoqol-100 compared with the 9-item Patient Health Questionnaire (PHQ-9) and Burns Depression Scale Today (BDST) in South Auckland, New Zealand.
METHOD: Consecutive patients with suspected low mood, seen over 22 months in a single primary care clinic by one of the authors, were eligible for this retrospective audit (n = 160). The index test was the verbally asked Emoqol-100: 'How is your emotional quality of life now, with 100 being perfect and 0 being the worst imaginable?' The reference standard was the PHQ-9 (n = 426 visits) with a cut-off point of ≥10 or BDST (n = 513 visits) with a cut-off point of ≥6.
RESULTS: The Emoqol-100 range 0-20 had a likelihood ratio (LR) of 25.2 for low mood compared with the BDST as the reference standard; and for Emoqol-100 scores of 21-40, 41-60, 61-80, and 81-100 the LRs were 3.6, 1.7, 0.35, and 0.09, respectively. For the PHQ-9, these were 10.1, 2.9, 1.3, 0.40, and 0.2, respectively. Any score ≤60 was associated with a low mood.
CONCLUSION: The Emoqol-100 appears to have high validity, so when it is low (≤60), it is suggestive of a high PHQ-9 or BDST score, and a mood issue probably exists. Emoqol-100 could be helpful for busy primary care professionals and other clinicians.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
BJGP open - 7(2023), 3 vom: 09. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dahle, Nina Edel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Audit |
|---|
| Anmerkungen: |
Date Revised 17.11.2023 published: Electronic-Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3399/BJGPO.2023.0011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356632733 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356632733 | ||
| 003 | DE-627 | ||
| 005 | 20231226070856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3399/BJGPO.2023.0011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356632733 | ||
| 035 | |a (NLM)37160336 | ||
| 035 | |a (PII)BJGPO.2023.0011 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dahle, Nina Edel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emoqol-100 |b Development and validation of a single question for low mood in primary care. A retrospective audit |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.11.2023 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023, The Authors. | ||
| 520 | |a BACKGROUND: Patients with depression need to be diagnosed and managed effectively in primary care. However, current inventories for case-finding low mood are time-consuming when considering the limited time available during appointments | ||
| 520 | |a AIM: To validate the diagnostic accuracy of a single question on the emotional quality of life (Emoqol-100) as a measure of depression in symptomatic patients | ||
| 520 | |a DESIGN & SETTING: A retrospective clinical audit, validating the Emoqol-100 compared with the 9-item Patient Health Questionnaire (PHQ-9) and Burns Depression Scale Today (BDST) in South Auckland, New Zealand | ||
| 520 | |a METHOD: Consecutive patients with suspected low mood, seen over 22 months in a single primary care clinic by one of the authors, were eligible for this retrospective audit (n = 160). The index test was the verbally asked Emoqol-100: 'How is your emotional quality of life now, with 100 being perfect and 0 being the worst imaginable?' The reference standard was the PHQ-9 (n = 426 visits) with a cut-off point of ≥10 or BDST (n = 513 visits) with a cut-off point of ≥6 | ||
| 520 | |a RESULTS: The Emoqol-100 range 0-20 had a likelihood ratio (LR) of 25.2 for low mood compared with the BDST as the reference standard; and for Emoqol-100 scores of 21-40, 41-60, 61-80, and 81-100 the LRs were 3.6, 1.7, 0.35, and 0.09, respectively. For the PHQ-9, these were 10.1, 2.9, 1.3, 0.40, and 0.2, respectively. Any score ≤60 was associated with a low mood | ||
| 520 | |a CONCLUSION: The Emoqol-100 appears to have high validity, so when it is low (≤60), it is suggestive of a high PHQ-9 or BDST score, and a mood issue probably exists. Emoqol-100 could be helpful for busy primary care professionals and other clinicians | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a audit | |
| 650 | 4 | |a depressive disorder | |
| 650 | 4 | |a diagnostic tests, routine | |
| 650 | 4 | |a general practitioners | |
| 650 | 4 | |a primary health care | |
| 700 | 1 | |a Matthew, Carolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Roskvist, Rachel Petronella |e verfasserin |4 aut | |
| 700 | 1 | |a Moir, Fiona |e verfasserin |4 aut | |
| 700 | 1 | |a Arroll, Bruce |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BJGP open |d 2017 |g 7(2023), 3 vom: 09. Sept. |w (DE-627)NLM29194342X |x 2398-3795 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:3 |g day:09 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3399/BJGPO.2023.0011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 3 |b 09 |c 09 | ||